Nitrofurantoin Glenmark Pharmaceuticals Europe

Nitrofurantoin, the active ingredient in Nitrofurantoin Glenmark Pharmaceuticals Europe, is a nitrofuran antibiotic presented as oral tablets for oral use. It treats uncomplicated urinary tract infections in adults and children.

GNH USA supplies Nitrofurantoin Glenmark Pharmaceuticals Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrofurantoin belongs to the nitrofuran antibiotic class and is used to manage infections of the urinary tract. - Uncomplicated urinary tract infections: eradicates common urinary pathogens and relieves infection symptoms. - Acute cystitis: provides rapid bactericidal activity against causative organisms in bladder infection. - Prophylaxis of recurrent urinary tract infections: reduces the frequency of repeat infections when used as a preventive regimen.

Adverse reactions to Nitrofurantoin may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach often occurring early in therapy. - Loss of appetite: reduced desire to eat during treatment. - Headache: transient cranial discomfort reported by some patients. - Diarrhoea: loose stools that usually resolve after continued dosing.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or acute respiratory distress, requiring immediate medical attention. - Hepatic injury: elevated liver enzymes or hepatitis, potentially severe. - Hemolytic anemia in G6PD deficiency: rapid destruction of red blood cells leading to jaundice and fatigue.

When prescribing Nitrofurantoin, clinicians should consider several safety aspects. - Renal function: assess creatinine clearance before initiating therapy to ensure adequate drug excretion. - G6PD deficiency: avoid use due to risk of hemolytic anemia. - Pregnancy: limit use to situations where benefits outweigh potential fetal risks, especially in the first trimester. - Elderly patients: monitor for signs of pulmonary toxicity and adjust dosing if needed. - Drug interactions: avoid concomitant use with antacids containing magnesium or aluminium, which can impair absorption. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nitrofurantoin may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing magnesium or aluminium: reduce oral absorption of Nitrofurantoin. - Probenecid: increases plasma concentrations, raising toxicity risk. - Warfarin: may potentiate anticoagulant effect, requiring closer INR monitoring.

Moderate Interactions (Monitor Closely): - NSAIDs: combined use can increase risk of renal impairment. - Diuretics: may affect renal clearance and drug levels. - Oral contraceptives: possible reduction in contraceptive effectiveness, advise additional contraceptive measures.